WEBINAR: The Science of ECP in Transplantation

Around 25% of organ transplant recipients encounter acute rejection within the first year post-transplantation. Acute rejection is further categorised into cellular (ACR) and antibody-mediated (AMR) forms. Over the long term, the threat shifts to chronic rejection, which poses a significant risk to graft function and patient survival.

Finding a balance between the beneficial and adverse effects of immunosuppression in preventing or treating rejection remains challenging. Factors such as opportunistic infections and malignancies further complicate this issue. Consequently, there is a keen interest in therapies that can effectively modulate alloimmune responses without suppressing the immune system’s ability to fight infection or malignancy.

Extracorporeal Photopheresis (ECP) presents a potential approach to achieving this balance in organ transplantation, although its precise mechanism of action has yet to be fully determined.

Programme:

• Introduction – Bill Scott
• Why is understanding ECP mechanisms important for clinicians? – Andrew Fisher 
• ECP in Solid Organ Transplantation – Mechanistic Perspectives – James Hutchinson
• Personalising the use of ECP in heart transplant recipients – Markus J. Barten 
• Q&A – Full Panel
• Wrap up and Closing remarks – Bill Scott

Please fill out the Webinar Registration to get an email for your direct access link.

Physicians, Scientists, Allied Health Care Professionals, Nurses, Patients